Zymfentra
Product Images NDC 72606-025

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Zymfentra (NDC 72606-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Zymfentra 1)

An instructional illustration showing a pen device labeled with parts before and after use. Before use, the diagram labels the cap, medicine, window, and body. After use, it highlights the needle cover and plunger rod inside the body, with the cap removed.*

FDA Label Image

Figure J (Zymfentra 10)

An instructional illustration showing the steps for using the ZYMFENTRA injection device. It depicts a hand pressing down the device twice, labeled as 'First (Click)' and 'Second (Click)', with a 10-second countdown during injection, followed by a slow count to 5 seconds before completing the injection.*

FDA Label Image

Figure K (Zymfentra 11)

An instructional illustration showing a hand holding a ZYMFENTRA 120 mg/mL injection pen. The image highlights removing the cap by pulling upwards from the injection site, with a close-up inset focusing on the pen tip area. The pen has a purple and white color scheme with a green cap.*

FDA Label Image

Figure L (Zymfentra 12)

An instructional diagram showing the needle cover on a syringe. The image highlights the needle cover at the bottom of the syringe with a label pointing to it, indicating its position and purpose as part of the injection device.*

FDA Label Image

Figure M (Zymfentra 13)

Illustration showing a hand holding a test strip with a purple test area, being inserted into a rectangular waste container or receptacle. The image appears to demonstrate the proper disposal or handling of the test strip but does not include text or labels.*

FDA Label Image

Figure A (Zymfentra 14)

An instructional diagram showing a prefilled syringe of ZYMFENTRA 120 mg/mL before and after use. The syringe parts labeled include the plunger, finger flange, body containing the medicine, needle, and cap. The 'Before Use' syringe has the needle cap removed, and the 'After Use' syringe shows the plunger fully depressed with the needle capped.*

FDA Label Image

Figure B (Zymfentra 15)

Illustration of a syringe-like device with a plunger at the top and a needle cover at the bottom. A callout magnifies a section of the syringe barrel, showing an expiration date field labeled as EXP: YYYY/MM.*

FDA Label Image

Figure C (Zymfentra 16)

An illustration showing a syringe-like applicator with a green plunger and purple flange. A magnified inset highlights a specific feature in the transparent barrel portion of the device, possibly indicating an internal marking or measurement area. No product text or labeling is visible in the image.*

FDA Label Image

Figure D (Zymfentra 17)

An instructional illustration divided into two sections. The top section shows a clock face with "30 minutes" indicating a time interval. The bottom section depicts a syringe-like applicator with a purple hub and a green plunger, likely related to the administration or preparation of ZYMFENTRA 120 mg/mL.*

FDA Label Image

Figure E (Zymfentra 18)

An instructional diagram illustrating appropriate injection sites for ZYMFENTRA 120 mg/mL. Areas marked in gray on the upper arms are for caregiver-only injections. Areas in green on the abdomen and front thighs are for both self-injection and caregiver usage.*

FDA Label Image

Figure F (Zymfentra 19)

An instructional illustration showing hands being washed under a running faucet with water flowing into a sink, demonstrating proper handwashing technique.*

FDA Label Image

Figure B (Zymfentra 2)

An illustration of a ZYMFENTRA single-dose vial or pen showing the location of the expiration date printing on the product container, highlighted with a circular zoom-in magnifying the text 'EXP.: YYYY/MM'.*

FDA Label Image

Figure G (Zymfentra 20)

An illustration showing a hand holding a cloth or wipe cleaning the skin on a shoulder area with accompanying text that reads 'Clean your skin.' This image appears instructional, demonstrating how to properly clean the skin, likely as part of medication administration or preparation guidelines.*

FDA Label Image

Figure H (Zymfentra 21)

Instructional diagram showing a hand attaching a small cap or component onto a syringe-like device labeled ZYMFENTRA 120 mg/mL. The image depicts the component being aligned and inserted, with an inset illustrating disposal or placement of the cap into a container, indicating safe handling or preparation steps for the product.*

FDA Label Image

Figure I (Zymfentra 22)

An instructional diagram showing a hand injecting with a syringe at a 45-degree angle into the skin of a patient's forearm. The image highlights the injection angle with a labeled 45-degree mark for proper administration technique.*

FDA Label Image

Figure J (Zymfentra 23)

An instructional illustration showing a hand holding a syringe inserted into a surface, with a black arrow indicating the direction of the action, likely related to preparation or administration of an injection.*

FDA Label Image

Figure K (Zymfentra 24)

An instructional illustration showing a hand holding a syringe with a purple ring, inserting the needle into a raised area of skin on an arm. A black arrow points toward the skin, indicating the direction of injection.*

FDA Label Image

Figure L (Zymfentra 25)

An instructional diagram showing a hand holding a syringe, poised to place the syringe into a sharps disposal container. The illustration depicts safe disposal of a used injection device, emphasizing proper handling techniques.*

FDA Label Image

Figure A (Zymfentra 26)

An instructional diagram showing the components and use of a prefilled syringe for ZYMFENTRA 120 mg/mL. The syringe parts labeled include the plunger, finger flange, viewing window, needle guard, needle, and cap. It illustrates the syringe before and after use, highlighting the position of the needle guard and cap.*

FDA Label Image

Figure B (Zymfentra 27)

An instructional illustration showing a syringe with an enlarged detail highlighting the location where the expiration date (format YYYY/MM) is printed on the syringe barrel. The image focuses on how to identify the expiration date on the syringe of the ZYMFENTRA product.*

FDA Label Image

Figure C (Zymfentra 28)

An instructional diagram illustrating a medical injector or syringe with a focus on the tip or inner needle design, shown in a zoomed circular inset. The device includes a green plunger and a purple component near the needle.*

FDA Label Image

Figure D (Zymfentra 29)

An illustration showing a syringe with a purple plunger and green thumb rest, accompanied by a clock icon indicating a 30-minute time interval. This likely represents a timing or administration instruction related to the ZYMFENTRA product.*

FDA Label Image

Figure C (Zymfentra 3)

An illustration showing a single ZYMFENTRA 120 mg/mL injection pen with a close-up inset highlighting the dose display window on the pen's side.*

FDA Label Image

Figure E (Zymfentra 30)

An instructional diagram showing preferred injection sites on a human body for ZYMFENTRA 120 mg/mL. Areas marked in green indicate sites for self-injection and caregiver administration, including the abdomen and thighs. Areas marked in gray indicate sites for caregiver-only administration, specifically the upper arms.*

FDA Label Image

Figure F (Zymfentra 31)

An illustration showing hands being washed under a running faucet with water flowing down into a sink, demonstrating proper handwashing technique.*

FDA Label Image

Figure G (Zymfentra 32)

An illustration showing a hand cleaning skin with a cloth or wipe. The text advises to 'Clean your skin,' indicating a preparatory step for product application or treatment.*

FDA Label Image

Figure H (Zymfentra 33)

An instructional illustration showing two hands handling a medical device component, demonstrating how to separate or attach parts. The inset circle emphasizes placing a small cylindrical piece into a holder or container.*

FDA Label Image

Figure I (Zymfentra 34)

An instructional illustration showing a hand administering an injection at a 45-degree angle to the shoulder area. The image demonstrates proper syringe positioning for an injection.*

FDA Label Image

Figure J (Zymfentra 35)

An instructional illustration showing a hand holding an injection device positioned against the skin on an upper arm, with an arrow indicating the direction to press or inject. This diagram is likely related to the administration of ZYMFENTRA 120 mg/mL injection by CELLTRION USA Inc.*

FDA Label Image

Figure K (Zymfentra 36)

An instructional illustration showing a hand holding a ZYMFENTRA injection syringe near a bent knee, with an arrow indicating the direction to insert the syringe into the skin, demonstrating the injection technique.*

FDA Label Image

Figure L (Zymfentra 37)

An instructional illustration showing a hand disposing of a syringe into a sharps disposal container. The image demonstrates safe and proper disposal of used syringes to prevent injury and contamination.*

FDA Label Image

Principal Display Panel (120 mg/mL Prefilled Pen Label)

Label for ZYMFENTRA 120 mg/mL injection, containing infliximab-dyyb, intended for subcutaneous use. The label includes the labeler name CELLTRION USA Inc. and specifies that the product is Rx only.*

FDA Label Image

Principal Display Panel (120 mg/mL Prefilled Pen Carton)

ZYMFENTRA 120 mg/mL injection label showing infliximab-dyyb as the active ingredient. The label indicates it is designed for subcutaneous use only and contains 1 single-dose prefilled pen along with 2 alcohol prep pads. The labeler is CELLTRION USA Inc.*

FDA Label Image

Figure D (Zymfentra 4)

An instructional illustration showing a clock indicating 30 minutes, paired with an image of a digital pen-like device. This likely represents a waiting period of 30 minutes related to the device shown, without additional context or text.*

FDA Label Image

Principal Display Panel (120 mg/mL Prefilled Syringe with Needle Guard)

ZYMFENTRA 120 mg/mL vial label featuring infliximab-dyyb as the active ingredient. The label includes the NDC 72606-025-09 and indicates subcutaneous use. It is labeled by CELLTRION USA Inc. with lot number LMI92507-LA001. The label states prescription only (Rx only).*

FDA Label Image

Principal Display Panel (120 mg/mL Prefilled Syringe with Needle Guard)

ZYMFENTRA 120 mg/mL injection label displaying the proprietary name, active ingredient infliximab-dyyb, and strength. The label specifies subcutaneous use only, includes a warning to dispense the enclosed medication guide, and shows packaging contents including one single-dose prefilled syringe with needle guard and two alcohol prep pads. The labeler is CELLTRION USA Inc.*

FDA Label Image

Principal Display Panel (120 mg/mL Prefilled Syringe Label)

ZYMFENTRA 120 mg/mL injection label showing the proprietary name, strength, form, and that it is for subcutaneous use. The active ingredient listed is infliximab-abda. The label includes the NDC number and indicates the product is Rx only. Labeler is CELLTRION USA Inc.*

FDA Label Image

Principal Display Panel (120 mg/mL Prefilled Syringe Carton)

ZYMFENTRA 120 mg/mL injection label showing the active ingredient infliximab-dyyb. The label indicates this is for subcutaneous use only and includes one single-dose prefilled syringe plus two alcohol prep pads. The product is labeled by CELLTRION USA Inc. with an NDC code present.*

FDA Label Image

Figure E (Zymfentra 5)

An anatomical illustration showing recommended injection sites for ZYMFENTRA 120 mg/mL. Dark gray areas on the upper arms indicate sites for caregiver-only injections, while green areas on the abdomen and front thighs indicate sites suitable for both self-injection and caregiver administration.*

FDA Label Image

Figure F (Zymfentra 6)

An illustration showing hands under a running faucet with water flowing, demonstrating handwashing or rinsing technique.*

FDA Label Image

Figure G (Zymfentra 7)

An instructional illustration shows a person seated, using a wipe to clean the skin on their upper thigh. The image includes the text 'Clean your skin,' indicating a step in preparing the injection site, likely related to ZYMFENTRA 120 mg/mL administration guidance.*

FDA Label Image

Figure H (Zymfentra 8)

Illustration showing how to remove the needle cover from a ZYMFENTRA injection pen. The image depicts a hand pulling the needle cover straight off the device with an arrow indicating the direction, and an inset showing the removed needle cover being discarded into a sharps container.*

FDA Label Image

Figure I (Zymfentra 9)

An instructional diagram showing two hand positions for holding a device at a 90-degree angle against the skin on the thigh or abdomen. The diagram demonstrates how to properly position the device for administration at either site.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.